Clinical Trial Update: Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 study of acalabrutinib with or without obinutuzumab in patients with early-stage chronic lymphocytic leukemia or smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Acalabrutinib (acalabrutinib)
• Obinutuzumab (obinutuzumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Status: RECRUITING